vs
优尼威尔（DSGR）与Hims & Hers Health, Inc.（HIMS）财务数据对比。点击上方公司名可切换其他公司
Hims & Hers Health, Inc.的季度营收约是优尼威尔的1.2倍（$617.8M vs $518.0M），Hims & Hers Health, Inc.净利率更高（3.3% vs 1.2%，领先2.1%），Hims & Hers Health, Inc.同比增速更快（28.4% vs 10.7%），优尼威尔自由现金流更多（$32.9M vs $-2.5M），过去两年Hims & Hers Health, Inc.的营收复合增速更高（49.0% vs 13.1%）
优尼威尔解决方案公司是一家全球化化学品与原料分销商，同时可为客户提供各类增值服务，业务网络覆盖全球多个地区，在化工及原料分销领域拥有丰富的行业经验与资源积累。
Hims & Hers Health, Inc.是2017年成立的美国远程医疗企业，面向消费者提供处方药品、非处方药物以及各类个人护理产品，依托线上服务模式为用户打造便捷的健康消费渠道，覆盖日常医疗、个护等多场景需求。
DSGR vs HIMS — 直观对比
营收规模更大
HIMS
是对方的1.2倍
$518.0M
营收增速更快
HIMS
高出17.7%
10.7%
净利率更高
HIMS
高出2.1%
1.2%
自由现金流更多
DSGR
多$35.4M
$-2.5M
两年增速更快
HIMS
近两年复合增速
13.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $518.0M | $617.8M |
| 净利润 | $6.5M | $20.6M |
| 毛利率 | 32.9% | 71.9% |
| 营业利润率 | 4.6% | 1.5% |
| 净利率 | 1.2% | 3.3% |
| 营收同比 | 10.7% | 28.4% |
| 净利润同比 | -70.6% | -20.8% |
| 每股收益（稀释后） | $0.14 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DSGRHIMS
| Q4 25 | — | $617.8M | ||
| Q3 25 | $518.0M | $599.0M | ||
| Q2 25 | $502.4M | $544.8M | ||
| Q1 25 | $478.0M | $586.0M | ||
| Q4 24 | $480.5M | $481.1M | ||
| Q3 24 | $468.0M | $401.6M | ||
| Q2 24 | $439.5M | $315.6M | ||
| Q1 24 | $416.1M | $278.2M |
净利润DSGRHIMS
| Q4 25 | — | $20.6M | ||
| Q3 25 | $6.5M | $15.8M | ||
| Q2 25 | $5.0M | $42.5M | ||
| Q1 25 | $3.3M | $49.5M | ||
| Q4 24 | $-25.9M | $26.0M | ||
| Q3 24 | $21.9M | $75.6M | ||
| Q2 24 | $1.9M | $13.3M | ||
| Q1 24 | $-5.2M | $11.1M |
毛利率DSGRHIMS
| Q4 25 | — | 71.9% | ||
| Q3 25 | 32.9% | 73.8% | ||
| Q2 25 | 33.9% | 76.4% | ||
| Q1 25 | 34.3% | 73.5% | ||
| Q4 24 | 33.3% | 76.8% | ||
| Q3 24 | 33.9% | 79.2% | ||
| Q2 24 | 34.5% | 81.3% | ||
| Q1 24 | 34.5% | 82.4% |
营业利润率DSGRHIMS
| Q4 25 | — | 1.5% | ||
| Q3 25 | 4.6% | 2.0% | ||
| Q2 25 | 5.3% | 4.9% | ||
| Q1 25 | 4.2% | 9.9% | ||
| Q4 24 | 4.2% | 3.9% | ||
| Q3 24 | 4.0% | 5.6% | ||
| Q2 24 | 3.2% | 3.5% | ||
| Q1 24 | 0.7% | 3.6% |
净利率DSGRHIMS
| Q4 25 | — | 3.3% | ||
| Q3 25 | 1.2% | 2.6% | ||
| Q2 25 | 1.0% | 7.8% | ||
| Q1 25 | 0.7% | 8.4% | ||
| Q4 24 | -5.4% | 5.4% | ||
| Q3 24 | 4.7% | 18.8% | ||
| Q2 24 | 0.4% | 4.2% | ||
| Q1 24 | -1.3% | 4.0% |
每股收益（稀释后）DSGRHIMS
| Q4 25 | — | $0.08 | ||
| Q3 25 | $0.14 | $0.06 | ||
| Q2 25 | $0.11 | $0.17 | ||
| Q1 25 | $0.07 | $0.20 | ||
| Q4 24 | $-0.55 | $0.10 | ||
| Q3 24 | $0.46 | $0.32 | ||
| Q2 24 | $0.04 | $0.06 | ||
| Q1 24 | $-0.11 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.2M | $228.6M |
| 总债务越低越好 | $665.5M | — |
| 股东权益账面价值 | $653.9M | $540.9M |
| 总资产 | $1.8B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.02× | — |
8季度趋势，按日历期对齐
现金及短期投资DSGRHIMS
| Q4 25 | — | $228.6M | ||
| Q3 25 | $69.2M | $345.8M | ||
| Q2 25 | $47.4M | $1.1B | ||
| Q1 25 | $65.4M | $273.7M | ||
| Q4 24 | $66.5M | $220.6M | ||
| Q3 24 | $61.3M | $165.5M | ||
| Q2 24 | $46.8M | $129.3M | ||
| Q1 24 | $73.1M | $105.2M |
总债务DSGRHIMS
| Q4 25 | — | — | ||
| Q3 25 | $665.5M | — | ||
| Q2 25 | $675.0M | — | ||
| Q1 25 | $712.4M | — | ||
| Q4 24 | $693.9M | — | ||
| Q3 24 | $704.1M | — | ||
| Q2 24 | $573.7M | — | ||
| Q1 24 | $535.7M | — |
股东权益DSGRHIMS
| Q4 25 | — | $540.9M | ||
| Q3 25 | $653.9M | $581.0M | ||
| Q2 25 | $649.4M | $562.7M | ||
| Q1 25 | $636.7M | $549.3M | ||
| Q4 24 | $640.5M | $476.7M | ||
| Q3 24 | $680.8M | $440.1M | ||
| Q2 24 | $653.3M | $362.0M | ||
| Q1 24 | $654.7M | $344.5M |
总资产DSGRHIMS
| Q4 25 | — | $2.2B | ||
| Q3 25 | $1.8B | $2.2B | ||
| Q2 25 | $1.8B | $1.9B | ||
| Q1 25 | $1.8B | $891.7M | ||
| Q4 24 | $1.7B | $707.5M | ||
| Q3 24 | $1.8B | $602.3M | ||
| Q2 24 | $1.6B | $480.5M | ||
| Q1 24 | $1.5B | $448.1M |
负债/权益比DSGRHIMS
| Q4 25 | — | — | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.82× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $61.3M |
| 自由现金流经营现金流 - 资本支出 | $32.9M | $-2.5M |
| 自由现金流率自由现金流/营收 | 6.3% | -0.4% |
| 资本支出强度资本支出/营收 | 1.1% | 10.3% |
| 现金转化率经营现金流/净利润 | 5.95× | 2.98× |
| 过去12个月自由现金流最近4个季度 | $92.2M | $57.4M |
8季度趋势，按日历期对齐
经营现金流DSGRHIMS
| Q4 25 | — | $61.3M | ||
| Q3 25 | $38.4M | $148.7M | ||
| Q2 25 | $33.3M | $-19.1M | ||
| Q1 25 | $-4.8M | $109.1M | ||
| Q4 24 | $45.7M | $86.4M | ||
| Q3 24 | $-17.3M | $85.3M | ||
| Q2 24 | $21.4M | $53.6M | ||
| Q1 24 | $6.6M | $25.8M |
自由现金流DSGRHIMS
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $32.9M | $79.3M | ||
| Q2 25 | $28.7M | $-69.5M | ||
| Q1 25 | $-10.4M | $50.1M | ||
| Q4 24 | $41.1M | $59.5M | ||
| Q3 24 | $-20.5M | $79.4M | ||
| Q2 24 | $18.0M | $47.6M | ||
| Q1 24 | $4.2M | $11.8M |
自由现金流率DSGRHIMS
| Q4 25 | — | -0.4% | ||
| Q3 25 | 6.3% | 13.2% | ||
| Q2 25 | 5.7% | -12.8% | ||
| Q1 25 | -2.2% | 8.5% | ||
| Q4 24 | 8.6% | 12.4% | ||
| Q3 24 | -4.4% | 19.8% | ||
| Q2 24 | 4.1% | 15.1% | ||
| Q1 24 | 1.0% | 4.3% |
资本支出强度DSGRHIMS
| Q4 25 | — | 10.3% | ||
| Q3 25 | 1.1% | 11.6% | ||
| Q2 25 | 0.9% | 9.3% | ||
| Q1 25 | 1.2% | 10.1% | ||
| Q4 24 | 1.0% | 5.6% | ||
| Q3 24 | 0.7% | 1.5% | ||
| Q2 24 | 0.8% | 1.9% | ||
| Q1 24 | 0.6% | 5.0% |
现金转化率DSGRHIMS
| Q4 25 | — | 2.98× | ||
| Q3 25 | 5.95× | 9.43× | ||
| Q2 25 | 6.66× | -0.45× | ||
| Q1 25 | -1.46× | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | -0.79× | 1.13× | ||
| Q2 24 | 11.28× | 4.03× | ||
| Q1 24 | — | 2.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
HIMS
暂无分部数据
